<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Hum Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Hum. Genet</journal-id>
<journal-title-group>
<journal-title>Journal of Human Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1434-5161</issn>
<issn pub-type="epub">1435-232X</issn>
<publisher>
<publisher-name>Springer Singapore</publisher-name>
<publisher-loc>Singapore</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31827250</article-id>
<article-id pub-id-type="pmc">6983459</article-id>
<article-id pub-id-type="publisher-id">698</article-id>
<article-id pub-id-type="doi">10.1038/s10038-019-0698-x</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Identification of novel <italic>FBN1</italic> variations implicated in congenital scoliosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Mao</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Sen</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Gang</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Yingzhao</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Chenxi</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Yanxue</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Lianlei</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yuanqiang</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yan</surname>
<given-names>Zihui</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Shengru</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Sen</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Jiaqi</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ye</surname>
<given-names>Yongyu</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Yaping</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Xu</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tong</surname>
<given-names>Bingdu</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Zheng</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Xinzhuang</given-names>
</name>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Niu</surname>
<given-names>Yuchen</given-names>
</name>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Xiaoxin</given-names>
</name>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yipeng</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Su</surname>
<given-names>Jianzhong</given-names>
</name>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname>
<given-names>Jian</given-names>
</name>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Hengqiang</given-names>
</name>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Shuyang</given-names>
</name>
<xref ref-type="aff" rid="Aff11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qiu</surname>
<given-names>Guixing</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<collab>on behalf of the Deciphering Disorders Involving Scoliosis and COmorbidities (DISCO) study<contrib-group><contrib contrib-type="author"><name><surname>Qiu</surname><given-names>Guixing</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Zhihong</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Jianguo</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Nan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Shengru</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Jiaqi</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Sen</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zuo</surname><given-names>Yuzhi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Gang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Yuanqiang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Chenxi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Sen</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Lianlei</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Yanxue</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Zihui</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Xinzhuang</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Hengqiang</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Niu</surname><given-names>Yuchen</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Xiaoxin</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Lin</surname><given-names>Mao</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib></contrib-group></collab>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ikegawa</surname>
<given-names>Shiro</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Jianguo</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wu</surname>
<given-names>Zhihong</given-names>
</name>
<address>
<email>wuzh3000@126.com</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff8">8</xref>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9429-2889</contrib-id>
<name>
<surname>Wu</surname>
<given-names>Nan</given-names>
</name>
<address>
<email>dr.wunan@pumch.cn</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0662 3178</institution-id><institution-id institution-id-type="GRID">grid.12527.33</institution-id><institution>Department of Orthopedic Surgery, Peking Union Medical College Hospital, </institution><institution>Peking Union Medical College and Chinese Academy of Medical Sciences, </institution></institution-wrap>Beijing, 100730 China </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0662 3178</institution-id><institution-id institution-id-type="GRID">grid.12527.33</institution-id><institution>Graduate School of Peking Union Medical College, </institution><institution>Chinese Academy of Medical Sciences, </institution></institution-wrap>Beijing, 100005 China </aff>
<aff id="Aff3"><label>3</label>Laboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, 108-8639 Japan </aff>
<aff id="Aff4"><label>4</label>Beijing Key Laboratory for Genetic Research of Skeletal Deformity, Beijing, 100730 China </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9889 6335</institution-id><institution-id institution-id-type="GRID">grid.413106.1</institution-id><institution>Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, </institution><institution>Chinese Academy of Medical Sciences and Peking Union Medical College, </institution></institution-wrap>Beijing, 100021 China </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.412615.5</institution-id><institution>Department of Joint Surgery, </institution><institution>First Affiliated Hospital of Sun Yat-sen University, </institution></institution-wrap>#58 Zhongshan 2nd Road, Guangzhou, 510080 China </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9889 6335</institution-id><institution-id institution-id-type="GRID">grid.413106.1</institution-id><institution>Department of Medical Genetics, Institute of Basic Medical Sciences, </institution><institution>Chinese Academy of Medical Sciences and Peking Union Medical College, </institution></institution-wrap>Beijing, 100005 China </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9889 6335</institution-id><institution-id institution-id-type="GRID">grid.413106.1</institution-id><institution>Medical Research Center &amp; Department of Central Laboratory, </institution><institution>Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, </institution></institution-wrap>Beijing, 100730 China </aff>
<aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0662 3178</institution-id><institution-id institution-id-type="GRID">grid.12527.33</institution-id><institution>Medical Research Center of Orthopedics, </institution><institution>Chinese Academy of Medical Sciences, </institution></institution-wrap>Beijing, 100730 China </aff>
<aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0348 3990</institution-id><institution-id institution-id-type="GRID">grid.268099.c</institution-id><institution>School of Ophthalmology &amp; Optometry and Eye Hospital, School of Biomedical Engineering, Institute of Biomedical Big Data, </institution><institution>Wenzhou Medical University, </institution></institution-wrap>325027 Wenzhou, China </aff>
<aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0662 3178</institution-id><institution-id institution-id-type="GRID">grid.12527.33</institution-id><institution>Department of Cardiology, Peking Union Medical College Hospital, </institution><institution>Peking Union Medical College and Chinese Academy of Medical Sciences, </institution></institution-wrap>No. 1 Shuaifuyuan, Beijing, 100730 China </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>11</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>11</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2020</year>
</pub-date>
<volume>65</volume>
<issue>3</issue>
<fpage>221</fpage>
<lpage>230</lpage>
<history>
<date date-type="received">
<day>30</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>23</day>
<month>10</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>11</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Congenital scoliosis (CS) is a form of scoliosis caused by congenital vertebral malformations. Genetic predisposition has been demonstrated in CS. We previously reported that <italic>TBX6</italic> loss-of-function causes CS in a compound heterozygous model; however, this model can explain only 10% of CS. Many monogenic and polygenic CS genes remain to be elucidated. In this study, we analyzed exome sequencing (ES) data of 615 Chinese CS from the Deciphering Disorders Involving Scoliosis and COmorbidities (DISCO) project. Cosegregation studies for 103 familial CS identified a novel heterozygous nonsense variant, c.2649G&gt;A (p.Trp883Ter) in <italic>FBN1</italic>. The association between <italic>FBN1</italic> and CS was then analyzed by extracting <italic>FBN1</italic> variants from ES data of 574 sporadic CS and 828 controls; 30 novel variants were identified and prioritized for further analyses. A mutational burden test showed that the deleterious <italic>FBN1</italic> variants were significantly enriched in CS subjects (OR = 3.9, <italic>P</italic> = 0.03 by Fisher’s exact test). One missense variant, c.2613A&gt;C (p.Leu871Phe) was recurrent in two unrelated CS subjects, and in vitro functional experiments for the variant suggest that <italic>FBN1</italic> may contribute to CS by upregulating the transforming growth factor beta (TGF-β) signaling. Our study expanded the phenotypic spectrum of <italic>FBN1</italic>, and provided nove insights into the genetic etiology of CS.</p>
</abstract>
<kwd-group kwd-group-type="npg-subject">
<title>Subject terms</title>
<kwd>Medical genomics</kwd>
<kwd>Genetics research</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>the National Natural Science Foundation of China 81822030 Beijing Natural Science Foundation 7172175 CAMS Initiative Fund for Medical Sciences 2016-I2M-3-003 the Central Level Public Interest Program for Scientific Research Institute 2018RC31003 the National Key Research and Development Program of China 2018YFC0910506</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>the Central Level Public Interest Program for Scientific Research Institute 2018RC31003 the International Program Associate grant from RIKEN of Japan 190038</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Beijing Natural Science Foundation 7184232</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>CAMS Initiative Fund for Medical Sciences 2016-I2M-3-003 the National Key Research and Development Program of RIKEN &amp; Ministry of Science and Technology of China (RIKEN-MOST) 2016YFE0128400 RIKEN Incentive Research Projects 201801062228</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>the National Natural Science Foundation of China 81572097 and 81871746</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>the National Key Research and Development Program of China 2016YFC0901501</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>the National Natural Science Foundation of China 81772301 CAMS Initiative Fund for Medical Sciences 2016-I2M-3-003</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>grants from Japan Agency For Medical Research and Development (AMED) 18ek0109280, 18ek0109212 the National Key Research and Development Program of RIKEN &amp; Ministry of Science and Technology of China (RIKEN-MOST) 2016YFE0128400</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>the National Natural Science Foundation of China 81672123</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>the National Natural Science Foundation of China 81772299 CAMS Initiative Fund for Medical Sciences 2016-I2M-3-003,2016-I2M-2-006 and 2017-I2M-2-001 the National Key Research and Development Program of China 2018YFC0910506</institution>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s), under exclusive licence to The Japan Society of Human Genetics 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par2">Congenital scoliosis (CS) is a form of scoliosis caused by congenital vertebral malformations potentially resulting from formation failure, segmentation defects, or a combination of both [<xref ref-type="bibr" rid="CR1">1</xref>]. The prevalence of CS is ~0.5–1 per 1000 live births [<xref ref-type="bibr" rid="CR2">2</xref>]. As a major cause to infantile and adolescent disability, CS perturbs patient lives and daily activities both physically and psychologically [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
<p id="Par3">Genetic predisposition has been demonstrated in CS [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. CS is a consequence of single-gene mutations. We previously reported that a heterozygous 16p11.2 deletion or rare <italic>TBX6</italic> loss-of-function (LoF) variants together with a common hypomorphic risk haplotype composed by three SNPs in <italic>trans</italic> cause CS [<xref ref-type="bibr" rid="CR6">6</xref>]. We subsequently recapitulated this compound heterozygosity model in a gene-edited mouse [<xref ref-type="bibr" rid="CR7">7</xref>], and defined the unique and clinically actionable phenotype of a monogenic form of CS, <italic>TBX6</italic>-associated CS (TACS) [<xref ref-type="bibr" rid="CR8">8</xref>]. However, this model can explain only about 10% of CS [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Many other contributor genes remain to be elucidated.</p>
<p id="Par4">CS is also a consequence of multifactorial gene-environment mutual interaction [<xref ref-type="bibr" rid="CR10">10</xref>]. The susceptibility of some polygenic defects has been illustrated in CS cases, accompanied with multiple birth defects [<xref ref-type="bibr" rid="CR11">11</xref>]. Previous studies have reported several CS-associated genes, including <italic>PAX1</italic> (MIM #167411) [<xref ref-type="bibr" rid="CR12">12</xref>], <italic>PTK7</italic> (MIM #601890) [<xref ref-type="bibr" rid="CR13">13</xref>], <italic>DLL1</italic> (MIM #606582) [<xref ref-type="bibr" rid="CR14">14</xref>], <italic>DDR2</italic> (MIM #191311) [<xref ref-type="bibr" rid="CR15">15</xref>], <italic>T</italic> (MIM #601397) [<xref ref-type="bibr" rid="CR16">16</xref>], and numerous other genes are thus far known to cause phenotypes involving scoliosis with vertebral malformations; however, their potential contribution to CS has been poorly investigated.</p>
<p id="Par5">Here, as a part of the Deciphering Disorders Involving Scoliosis and COmorbidities (DISCO) project, we conducted exome sequencing (ES) for a CS cohort. Trio-based analyses on familial cases identified a novel nonsense variant in <italic>FBN1</italic>, the gene implicated in Marfan syndrome (MFS; MIM#154700) and many monogenic diseases with scoliosis and spinal dysplasia. We then examined the effect of rare <italic>FBN1</italic> variants on sporadic CS and observed that deleterious missense variants were significantly enriched in CS. Functional analyses of a recurrent <italic>FBN1</italic> missense variant revealed the potential association between upregulation of transforming growth factor beta (TGF-β) signaling and CS. The subjects carrying highly deleterious <italic>FBN1</italic> variants had vertebral malformations, malformations of the ribs, and intraspinal defects.</p>
</sec>
<sec id="Sec2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="Sec3">
<title>Participant recruitment</title>
<p id="Par6">Initially, 615 Chinese CS subjects with complete clinical data and ES data were recruited at Peking Union Medical College Hospital (PUMCH) in China from 2010 to 2018, as a pivotal part of DISCO study (<ext-link ext-link-type="uri" xlink:href="http://www.discostudy.org/">http://www.discostudy.org/</ext-link>). There were 103 familial cases with available samples for first-degree relatives. <italic>TBX</italic>6 mutations were examined and 41 cases molecularly diagnosed as TACS [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR8">8</xref>] were removed. Consequently, 574 CS cases were retained for further study. For the control subjects, 828 unrelated Chinese iindividuals without apparent spinal deformity were ascertained. The ethical committees or institutional review boards at PUMCH that contributed to the patient samples approved the study. Written informed consent was obtained from each participant or their guardians (for those younger than 16 years old).</p>
</sec>
<sec id="Sec4">
<title>Exome Sequencing and Sanger sequencing</title>
<p id="Par7">Genomic DNA from peripheral blood samples was extracted using the DNeasy Blood &amp; Tissue kit (Qiagen, Hilden, Germany). The ES data were processed and analyzed using the PUMCH Pipeline as previously described [<xref ref-type="bibr" rid="CR17">17</xref>]. The following public available databases were used for mutation annotation: the 1000 Genomes Project (1KG; <ext-link ext-link-type="uri" xlink:href="http://www.internationalgenome.org">http://www.internationalgenome.org</ext-link>), the Exome Sequencing Project (ESP; <ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">http://evs.gs.washington.edu/EVS/</ext-link>), Exome Aggregation Consortium (ExAC; <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org/</ext-link>), and Genome Aggregation Database (gnomAD; <ext-link ext-link-type="uri" xlink:href="http://gnomad-old.broadinstitute.org">http://gnomad-old.broadinstitute.org</ext-link>), Single Nucleotide Polymorphism database (dbSNP; <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/snp">https://www.ncbi.nlm.nih.gov/snp</ext-link>). In silico prediction tools, including Sorting Intolerant From Tolerant (SIFT) [<xref ref-type="bibr" rid="CR18">18</xref>], Polymorphism Phenotyping v2 (Polyphen-2) [<xref ref-type="bibr" rid="CR19">19</xref>], Mutation Taster [<xref ref-type="bibr" rid="CR20">20</xref>], and Combined Annotation Dependent Depletion (CADD) [<xref ref-type="bibr" rid="CR21">21</xref>] were utilized to predict deleterious properties of variants. We also annotated the detected variants using customized database based on Human Gene Mutation Database (HGMD; <ext-link ext-link-type="uri" xlink:href="http://www.hgmd.cf.ac.uk/">www.hgmd.cf.ac.uk/</ext-link>) and Online Mendelian Inheritance in Man (<ext-link ext-link-type="uri" xlink:href="https://omim.org/">https://omim.org/</ext-link>). Empirically, we utilized the recommended filters of the Genome Analysis Toolkit (v2.2–3) prior to performing association analyses in order to guarantee that the risk of false negatives is minimized to select quality control passed variants [<xref ref-type="bibr" rid="CR22">22</xref>]. Sanger sequencing by using an Applied Biosystem 3730xl DNA Analyzer (Life Technologies, CA, USA) was conducted to confirm the candidate variants identified by ES, and segregation analyses were performed in family members. The RefSeq accession numbers of the transcript and corresponding protein isoform of <italic>FBN1</italic> we used for mutation nomenclature were NM_000138.4 and NP_000129.3, respectively.</p>
</sec>
<sec id="Sec5">
<title>Mutational burden analyses</title>
<p id="Par8">Mutational burden analyses of <italic>FBN1</italic> were implemented between 574 CS cases and 828 controls. To alleviate the biased factors attributable to differential sequencing coverage, we conducted harmonization analyses between case and control exomes. An individual RefSeq coding sequence site was excluded from the analysis if the absolute difference in percentages of cases compared with controls with adequate coverage of the site differed by &gt;10%. This site-based pruning resulted in exclusion of 4.8% of the Refseq coding sequence sites. We also introduced a likely gene-disrupting (LGD) model [<xref ref-type="bibr" rid="CR23">23</xref>] to prioritize the candidate variants. The LGD model is defined by clustering LoF variants (nonsense, splice-site, and insertion/deletion). A damaging missense (D-mis) model was also applied for variant prioritization. D-mis is defined by selection of D-mis variants with a predicted CADD score ≥ 20. In viewing of the dominant traits that <italic>FBN1</italic> may have, inclusion criteria were strictly set to select the presumably LGD and D-mis variants to identify risk-conferring variants to CS. Variants that are not present at this time in 1KG, ESP, ExAC, dbSNP, the Universal Mutation Database for <italic>FBN1</italic> (UMD-FBN1; <ext-link ext-link-type="uri" xlink:href="http://www.umd.be/FBN1/">http://www.umd.be/FBN1/</ext-link>) [<xref ref-type="bibr" rid="CR24">24</xref>] were defined as “novel.” Only novel variants were subjected to the burden analysis. We applied a collapsing method [<xref ref-type="bibr" rid="CR25">25</xref>] to detect the association of mutational burden. The CADD score of 20, which corresponds to the top 1% of damage when evaluating all known allelic variants [<xref ref-type="bibr" rid="CR26">26</xref>], was set as the cutoff value for creating a stratified variants subgroup for collapsing.</p>
</sec>
<sec id="Sec6">
<title>Construction of expression plasmids</title>
<p id="Par9">We constructed a plasmid expressing full-length <italic>FBN1</italic> (GenBank: NM_000138.4) cDNA with enhanced green fluorescent protein (EGFP) fusion, pEGFP-FBN1. A full-length <italic>FBN1</italic> cDNA having suitable restriction sites was PCR-amplified using KOD-Plus-Neo (Toyobo, Japan). The PCR amplicons were cloned into the <italic>Nhe</italic>I and <italic>Sac</italic>II sites of the pEGFP-N1 expression vector (Clontech, Takara Bio, Japan). The construct for the Leu871Phe variant was generated by QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies, CA, USA). All plasmid constructs were subjected to Sanger sequencing for verification.</p>
</sec>
<sec id="Sec7">
<title>Cell culture and transfection</title>
<p id="Par10">HEK293T cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) (Gibco, Waltham, MA, USA) supplemented with 10% FCS (Biological Industries, CT, USA) and 1% penicillin/streptomycin (Gibco) at 37 °C with 5% CO<sub>2</sub>. Cells were seeded in a six-well plates and transfected with Lipofectamine™ 3000 Transfection Reagent (Invitrogen, CA, USA) according to the manufacturers’ instructions. The medium was replaced with fresh DMEM culture medium 6 h after transfection. The cells were further incubated for 48 h.</p>
</sec>
<sec id="Sec8">
<title>Real-time quantitative polymerase chain reaction</title>
<p id="Par11">Total RNA was isolated using an RNeasy<sup>®</sup> Mini Kit (Qiagen) and treated with RNase-Free DNase Set (Qiagen). Total RNA was reversely transcribed to cDNA by using the PrimeScript™ RT reagent Kit (#RR037A, Clontech). The relative abundance of targeted mRNA was normalized to glyceraldehyde-3-phosphate dehydrogenase (<italic>GAPDH</italic>). The primers 5’-CAAGGGCATCCTGGGCTACACT-3′ and 5′- CTCTCTCTTCCTCTTGTGCTCTTGC-3′ were used for amplification of <italic>GAPDH</italic>; 5′-ACCTGGTTACTTCCGCATAG-3′ and 5′-GAGGCATCAGTTTCGTTTGT-3′ were used for amplification of EGFP-FBN1. Gene expression was determined using SYBR Green PCR Master Mix (Applied Biosystems, CA, USA) on the 7500Fast Real-Time PCR Systems (Applied Biosystems).</p>
</sec>
<sec id="Sec9">
<title>Western blot analysis</title>
<p id="Par12">Cells were lysed with modified RIPA (50 mM Tris-HCL, 1% NP40, 0.25% Na-deoxycholate, 150 mM NaCl, and 1 mM EDTA; Complete<sup>TM</sup> Protease Inhibitor Cocktail [Roche, Mannheim, Germany]), and protein concentrations were determined with the Pierce<sup>TM</sup> BCA Protein Assay Kit (Pierce Biotechnology, Rockford, USA). A total of 5 mg protein was size separated on an 8% SDS polyacrylamide gel, and proteins were electrophoresed and transferred to nitrocellulose membranes. Membranes were blocked in powdered milk for 30 min at room temperature (RT, 25 °C), and primary antibodies (Phospho-Smad2 [Ser465/467] (138D4) Rabbit mAb #3108, Cell Signaling Technology, MA, USA; Smad2/3 [D7G7] XP<sup>®</sup> Rabbit mAb #8685, Cell Signaling Technology; Mouse Anti-β actin mAb, TA-09, ZSGB-bio, China) were incubated overnight at 4 °C. After washing, the corresponding horseradish-peroxidase-coupled IRDye<sup>®</sup> 800CW Goat anti-Mouse IgG Secondary Antibody (926-32210, LI-COR, NE, USA) were incubated for 1 h at RT. Bands were visualized with the WesternBright ECL HRP substrate chemiluminescent system (Advansta, CA, USA). Chemiluminescent signals were quantified using ImageJ [<xref ref-type="bibr" rid="CR27">27</xref>].</p>
</sec>
<sec id="Sec10">
<title>Statistical analyses</title>
<p id="Par13">A one-sided Fisher’s exact test or a one-sided Chi-square test was used for all mutational burden analyses by using SPSS Statistics 23.0 (SPSS Inc., Al Monk, NY, USA), and a Student's <italic>t</italic> test was used to compare the differences of qPCR and WB results. All cell experiments were independently repeated three times with different cell lysates for each single assay, and data were presented as mean ± S.E.M. A <italic>P</italic> value &lt; 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="Sec11" sec-type="results">
<title>Results</title>
<sec id="Sec12">
<title>Identification of a novel <italic>FBN1</italic> null variant transmitted in a CS family</title>
<p id="Par14">We applied ES to identify responsible variants with autosomal dominant inheritance in all 103 familial CS. We identified a maternally inherited LGD variant associated with the vertebral phenotypes in a family. The novel heterozygous LGD variant was c.2649G&gt;A (p.Trp883Ter) in <italic>FBN1</italic>, which co-segregated with CS in a dominant family (Fig. <xref ref-type="fig" rid="Fig1">1a, b</xref>). The nonsense variant was considered to exert a significant LoF effect by triggering the nonsense-mediated mRNA decay mechanism and subsequently loss of FBN1 protein. The proband III-1 displayed CS with structural segmentation defect of the vertebrae (T10-L1) and the formation of vertebral bar on the left side (T10-L1) (Fig. <xref ref-type="fig" rid="Fig1">1c</xref>), whereas the mother II-2 exhibited severe congenital kyphosis with segmentation defects (Fig. <xref ref-type="fig" rid="Fig1">1d</xref>). Although the mitral valve prolapse with mild mitral insufficiency was found in the proband, no other apparent cardiovascular or ocular phenotypes featuring MFS were identified in the proband and his mother. The aortic root measurements of the proband still remained normal (<italic>Z</italic> score = 1.4) by echocardiographic measurements, and the diagnosis of MFS could not be implemented according to the Ghent Criteria [<xref ref-type="bibr" rid="CR28">28</xref>]. As for now, no obvious “marfanoid” appearances are observed in the family members. i.e., III-1 and II-2 (Supplementary Table <xref ref-type="media" rid="MOESM1">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>The family with congenital scoliosis and an <italic>FBN1</italic> nonsense variant, c.2649G&gt;A (p.Trp883Ter). <bold>a</bold> Pedigree and segregation of the variant. <bold>b</bold> Electropherograms of Sanger sequencing showing the heterozygous c.2649G&gt;A in the proband (III-1) and his mother (II-2). Ref., the reference sequence. Black arrows indicate the nucleotide substitution positions. <bold>c</bold> Anteroposterior and lateral X-ray film of the whole spine of the proband III-1 displaying congenital scoliosis with segmentation defects of thoracic 10-lumbar 1 spine with formation of vertebral bar on the left. <bold>d</bold> Lateral X-ray film of the whole spine of II-2 showing severe congenital kyphosis with segmentation defects.</p></caption><graphic id="d29e1086" xlink:href="10038_2019_698_Fig1_HTML"></graphic></fig></p>
<p id="Par15">In addition, we did not observe any LoF variants other than the <italic>FBN1</italic> p.Trp883Ter in any of the family members.</p>
</sec>
<sec id="Sec13">
<title>Novel deleterious coding variants in <italic>FBN1</italic> are enriched in CS patients</title>
<p id="Par16">Concerning the potential association between <italic>FBN1</italic> and CS, we further compared the difference of the frequency of <italic>FBN1</italic> variants between sporadic CS cases and controls. We subsequently identified a total of 30 novel variants (28 missense, 1 frameshift, and 1 splicing variant) in 16 out of the 574 CS cases and 14 out of 828 in-house controls. When all 30 variants were evaluated by the collapsing method, no significant association with CS was observed (OR = 1.6, <italic>P</italic> = 0.15 by one-sided Chi-square test). Next, the variants were stratified based on their deleteriousness determined by the CADD score. In the group of CADD score &lt; 20, a total of 19 variants were subjected to the collapsed analysis without mutation types stratification and no statistical difference was identified. Further stratification within this group based on mutation types did not show any statistical difference in any mutation types (Table <xref ref-type="table" rid="Tab1">1</xref>). In contrast, in the group of CADD score ≥ 20, a total of 11 missense variants were identified; eight in CS and three in controls, respectively. The eight missense variants (including one recurrent variant) were significantly enriched in CS (OR = 3.9, <italic>P</italic> = 0.03 by one-sided Fisher’s exact test) (Table <xref ref-type="table" rid="Tab1">1</xref>). Sanger sequencing results of the eight cases are shown in Supplementary Fig. <xref ref-type="media" rid="MOESM3">1</xref>. Intriguingly, we have also checked the <italic>FBN1</italic> mutations in our study but did not identify any overlapping variants with the idiopathic scoliosis cohort reported by Buchan et al. [<xref ref-type="bibr" rid="CR29">29</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Mutational burden analysis of <italic>FBN1</italic> variants in congenital scoliosis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Variant</th><th rowspan="2">Total number of variants</th><th colspan="2">Number of alternative alleles</th><th rowspan="2">OR (95% CI)</th><th rowspan="2"><italic>P</italic> value</th></tr><tr><th>Congenital scoliosis (<italic>n</italic> = 574)</th><th>In-house control (<italic>n</italic> = 828)</th></tr></thead><tbody><tr><td>Total</td><td>30</td><td>16</td><td>14</td><td>1.6 (0.8–3.2)</td><td>0.15</td></tr><tr><td>CADD score &lt; 20</td><td>19</td><td>8</td><td>11</td><td>1.0 (0.4–2.6)</td><td>0.55</td></tr><tr><td> Frameshift</td><td>1</td><td>0</td><td>1</td><td>–</td><td>0.60</td></tr><tr><td> Splicing</td><td>1</td><td>1</td><td>0</td><td>–</td><td>0.41</td></tr><tr><td> Missense</td><td>17</td><td>7</td><td>10</td><td>1.0 (0.4–2.7)</td><td>0.60</td></tr><tr><td>CADD score ≥  20</td><td>11</td><td>8</td><td>3</td><td>3.9 (1.0–14.6)</td><td>0.03</td></tr><tr><td> Missense</td><td>11</td><td>8</td><td>3</td><td>3.9 (1.0–14.6)</td><td>0.03</td></tr></tbody></table><table-wrap-foot><p>Association in the allelic model was calculated using Fisher’s exact test. <italic>P</italic> value &lt; 0.05 was considered statistically significant</p><p><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval, <italic>CADD</italic> Combined Annotation Dependent Depletion</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec14">
<title>Genetic and phenotypic analyses of the CS individuals harboring candidate variants</title>
<p id="Par17">The genetic information and in silico deleteriousness predictions of the eight variants are presented in Table <xref ref-type="table" rid="Tab2">2</xref>. One missense variant: p.Leu871Phe (CADD score = 23.9) was recurrent in two unrelated CS subjects. Leu871 was located within the hybrid 2 motif region of the protein (Fig. <xref ref-type="fig" rid="Fig2">2</xref>), which is an evolutionary ‘hybrid’ between TGF-β binding protein-like (TB) and calcium-binding epidermal growth factor-like (cbEGF-like) domains [<xref ref-type="bibr" rid="CR30">30</xref>]. Previous studies indicated that mutations situated within this domain disrupted the ratio of an α-helix to β-sheet leading to a more compact conformation [<xref ref-type="bibr" rid="CR31">31</xref>]. In addition, conservation analysis of amino acid residue of Leu871 in <italic>FBN1</italic> indicated that it is highly conserved throughout evolution and across many selected species, suggesting it is required for the normal function of the protein (Fig. <xref ref-type="media" rid="MOESM4">S2</xref>). The remaining six missense variants predicted with highly deleterious properties were located in epidermal growth factor-like (EGF-like) domains or cbEGF-like domains (Fig. <xref ref-type="fig" rid="Fig2">2</xref>), playing a seminal role in diseases [<xref ref-type="bibr" rid="CR32">32</xref>].<table-wrap id="Tab2"><label>Table 2</label><caption><p>Candidate <italic>FBN1</italic> variants in congenital scoliosis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Subject ID</th><th>Genomic position<sup>a</sup></th><th>Nucleotide change<sup>b</sup></th><th>Protein change<sup>c</sup></th><th>Exon number</th><th>Family and domain</th><th colspan="2">AF in gnomAD</th><th colspan="4">In silico prediction tool<sup>d</sup></th></tr><tr><th></th><th></th><th></th><th></th><th></th><th></th><th>ALL</th><th>EAS</th><th>SIFT</th><th>Polyphen-2</th><th>Mutation taster</th><th>CADD score</th></tr></thead><tbody><tr><td>XH1162</td><td>48902987</td><td>c.284C&gt;G</td><td>p.Ser95Trp</td><td>4</td><td>EGF-like<sup>e</sup> #01</td><td>0</td><td>0</td><td>D</td><td>D</td><td>D</td><td>22.7</td></tr><tr><td>XH810</td><td>48807596</td><td>c.1456G&gt;T</td><td>p.Gly486Trp</td><td>12</td><td>EGF-like #04</td><td>0</td><td>0</td><td>D</td><td>D</td><td>D</td><td>24.6</td></tr><tr><td>XH152</td><td>48805763</td><td>c.1571C&gt;A</td><td>p.Thr524Lys</td><td>13</td><td>cbEGF-likef #03</td><td>0</td><td>0</td><td>T</td><td>D</td><td>D</td><td>32</td></tr><tr><td>XH73</td><td>48787384</td><td>c.2613A&gt;C</td><td>p.Leu871Phe</td><td>22</td><td>Hybrid motif #02</td><td>0.00000406</td><td>0.000058</td><td>D</td><td>D</td><td>D</td><td>23.9</td></tr><tr><td>XH579</td><td>48787384</td><td>c.2613A&gt;C</td><td>p.Leu871Phe</td><td>22</td><td>Hybrid motif #02</td><td>0.00000406</td><td>0.000058</td><td>D</td><td>D</td><td>D</td><td>23.9</td></tr><tr><td>XH766</td><td>48779535</td><td>c.3437T&gt;G</td><td>p.Leu1146Arg</td><td>28</td><td>cbEGF-like #13</td><td>0</td><td>0</td><td>D</td><td>P</td><td>D</td><td>26.4</td></tr><tr><td>XH902</td><td>48729214</td><td>c.6440G&gt;A</td><td>p.Gly2147Asp</td><td>53</td><td>cbEGF-like #32</td><td>0</td><td>0</td><td>T</td><td>D</td><td>D</td><td>34</td></tr><tr><td>XH441</td><td>48722914</td><td>c.6825C&gt;G</td><td>p.Ile2275Met</td><td>56</td><td>cbEGF-like #35</td><td>0</td><td>0</td><td>T</td><td>D</td><td>D</td><td>20.6</td></tr></tbody></table><table-wrap-foot><p><italic>gnomAD</italic> Genome Aggregation Database, <italic>AF</italic> allele frequency, <italic>ALL</italic> all populations, <italic>EAS</italic> east Asian, <italic>D</italic> damaging, <italic>P</italic> probably damaging, <italic>T</italic> tolerated</p><p><sup>a</sup>Chromosomal position based on GRCh37/hg19</p><p><sup>b,c</sup>The RefSeq transcript number of <italic>FBN1</italic> is NM_000138.4</p><p><sup>d</sup>In silico prediction tools to evaluate a genetic variant for its deleterious potential</p><p><sup>e</sup>Epidermal growth factor-like domain</p><p><sup>f</sup>Calcium-binding epidermal growth factor-like domain</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig. 2</label><caption><p>Schematic representation of the distribution of the candidate <italic>FBN1</italic> variants identified in congenital scoliosis. Protein structure is redrawn from the UMD-FBN1 database. Black dots indicate the location of missense and nonsense variants.</p></caption><graphic id="d29e1807" xlink:href="10038_2019_698_Fig2_HTML"></graphic></fig></p>
<p id="Par18">The eight subjects harbored the <italic>FBN1</italic> variants displayed different types of vertebral malformations (Table <xref ref-type="table" rid="Tab3">3</xref>). Malformations of the ribs were also found in three subjects (Table <xref ref-type="table" rid="Tab3">3</xref>). Notably, intraspinal defects (diastematomyelia, syringomyelia, and tethered cord) were identified in five subjects (Table <xref ref-type="table" rid="Tab3">3</xref>). Although mild mitral insufficiency and pectus carinatum deformity presented in XH902, aortic root measurements still remained normal (<italic>Z</italic> score = 1.6), and ocular phenotypes supporting MFS were not present. This patient would be categorized as “potential MFS” until the aorta reaches threshold (<italic>Z</italic> score = 3) [<xref ref-type="bibr" rid="CR28">28</xref>]. The remaining seven subjects had no cardiovascular or ocular manifestations (Table <xref ref-type="table" rid="Tab3">3</xref>), and hence they were not diagnosed as MFS. We have also re-evaluated the other marfanoid musculoskeletal phenotypes of these eight cases, and observed that no apparent manifestations except Patient XH902 with pectus carinatum deformity (Supplementary Table <xref ref-type="media" rid="MOESM2">2</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Phenotypic manifestations of the congenital scoliosis subjects with deleterious <italic>FBN1</italic> missense variants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Subject ID</th><th rowspan="2">Age (year)</th><th rowspan="2">Gender</th><th rowspan="2">MCA (degree)</th><th colspan="5">Malformation involved</th><th>Other complication</th></tr><tr><th>Vertebral</th><th>Costal</th><th>Intraspinal</th><th>Cardiovascular</th><th>Ocular</th><th></th></tr></thead><tbody><tr><td>XH1162</td><td>6</td><td>M</td><td>65</td><td>SD, FL, LF, H</td><td>N</td><td>N</td><td>N</td><td>N</td><td>Short neck</td></tr><tr><td>XH810</td><td>7</td><td>F</td><td>48</td><td>B</td><td>N</td><td>Tethered cord</td><td>N</td><td>N</td><td>N</td></tr><tr><td>XH152</td><td>11</td><td>M</td><td>72</td><td>H, W, FL</td><td>N</td><td>N</td><td>N</td><td>N</td><td>Pulmonary dysfunction</td></tr><tr><td>XH73</td><td>12</td><td>F</td><td>40</td><td>SD</td><td>Intercostal cohesion of bilateral 2–5th ribs</td><td>Diastematomyelia, hypoplastic spinal processes</td><td>N</td><td>N</td><td>N</td></tr><tr><td>XH579</td><td>2</td><td>M</td><td>104</td><td>W, FF, SD</td><td>Bilateral 12th rib absence</td><td>syringomyelia, tethered cord</td><td>N</td><td>N</td><td>Joint contractures</td></tr><tr><td>XH766</td><td>1</td><td>M</td><td>80</td><td>B, H</td><td>N</td><td>N</td><td>N</td><td>N</td><td>N</td></tr><tr><td>XH902</td><td>11</td><td>M</td><td>77</td><td>SD, W</td><td>N</td><td>Syringomyelia</td><td>Mitral insufficiency</td><td>N</td><td>Pectus carinatum</td></tr><tr><td>XH441</td><td>1</td><td>M</td><td>50</td><td>SD, FF, B</td><td>Bilateral 13th ribs</td><td>Diastematomyelia, syringomyelia</td><td>N</td><td>N</td><td>N</td></tr></tbody></table><table-wrap-foot><p><italic>MCA</italic> maximal Cobb angle, <italic>M</italic> male, <italic>F</italic> female, <italic>SD</italic> segmentation defect, <italic>FL</italic> fused lamina, <italic>LF</italic> lamina fissure, <italic>H</italic> hemivertebrae, <italic>B</italic> butterfly-vertebrae, <italic>W</italic> wedge-shaped vertebrae, <italic>FF</italic> formation failure of vertebrae, <italic>N</italic> not present</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec15">
<title>Functional study of the recurrent variant, Leu871Phe</title>
<p id="Par19">We overexpressed either human <italic>FBN1</italic> wild-type or p.Leu871Phe in HEK293T cells. Total RNA was reversely transcribed to cDNA 48 h after transfection. The mRNA expression level of the p.Leu871Phe FBN1 showed no statistical difference to that of the WT plasmid (<italic>P</italic> = 0.38 by Student’s <italic>t</italic> test) (Fig. <xref ref-type="fig" rid="Fig3">3a</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p>Functional analyses of the recurrent missense variant, c.2613A&gt;C (p.Leu871Phe). <bold>a</bold> The expression of <italic>FBN1</italic> mRNAs from HEK293T cells transfected with the empty vector (EV), wild type (WT), or mutant (p. Leu871Phe: L871F) <italic>FBN1</italic> plasmids. ns not significant. <bold>b</bold> Western blotting for the protein lysates. <bold>c, d</bold> Quantification of the western blotting results. The ratio of phosphorylated Smad2 and total Smad2 to β-actin are shown normalized to WT plasmid. Data are expressed as arbitrary units indicating mean ± SEM of three independent experiments. Statistical significance was calculated by Student’s <italic>t</italic> test, *<italic>P</italic> &lt; 0.05. ns not significant.</p></caption><graphic id="d29e2229" xlink:href="10038_2019_698_Fig3_HTML"></graphic></fig></p>
<p id="Par20">Previous studies have demonstrated that deleterious <italic>FBN1</italic> mutations upregulate endogenous TGF-β signaling, which could be measured via phosphorylation of Smad2 (p-Smad2), a downstream target [<xref ref-type="bibr" rid="CR33">33</xref>]. Transfected cells with the p.Leu871Phe FBN1 showed significantly elevated p-Smad2 level compared with the WT (<italic>P</italic> = 0.02 by Student’s <italic>t</italic> test) (Fig. <xref ref-type="fig" rid="Fig3">3b–d</xref>), while they showed no statistical difference in expression of total Smad2 compared with the WT (<italic>P</italic> = 0.96 by Student’s <italic>t</italic> test).</p>
</sec>
</sec>
<sec id="Sec16" sec-type="discussion">
<title>Discussion</title>
<p id="Par21">In the present study, we conducted family-based ES analysis and allele-based mutational burden analysis, and provided evidence for the genetic association between <italic>FBN1</italic> and CS. We then performed in vitro functional assay for a recurrent <italic>FBN1</italic> variant (p.Leu871Phe) and revealed the upregulation of TGF-β signaling caused by the variant. Clinical features for the CS cases with <italic>FBN1</italic> variants showed the expansion of the <italic>FBN1-</italic>related disease entity.</p>
<p id="Par22"><italic>FBN1</italic> encodes a connective tissue protein essential to extracellular microfibrils organization in dermal fibroblasts and skeletal muscle cells [<xref ref-type="bibr" rid="CR34">34</xref>]. <italic>FBN1</italic> is well known as a causal gene for MFS, which often has scoliosis without structural changes of the vertebrae and ribs. On the other hand, <italic>FBN1</italic> mutations also cause various skeletal dysplasia, including Acromicric dysplasia (MIM #102370), Geleophysic dysplasia 2 (MIM #614185), Marfan lipodystrophy syndrome (MIM #616914), and Weill–Marchesani syndrome 2 (MIM #608328). These monogenic diseases have a broad range of vertebral phenotypes quite different from MFS. In a previous study, a novel <italic>FBN1</italic> variant, p.Gly1796Glu co-segregated in a family with an autosomal dominant vertebral dysplasia featuring CS, in the absence of cardiac or ocular findings [<xref ref-type="bibr" rid="CR35">35</xref>], indicating that <italic>FBN1</italic> could be a disease gene for monogenic form of CS. Our case also confirmed that <italic>FBN1</italic> causes CS as an autosomal dominant disease trait pattern.</p>
<p id="Par23">The index case in our study was from an unusual three-generation CS family segregating <italic>FBN1</italic> LoF variant, c.2649G&gt;A (p.Trp883Ter), which has been previously reported to be a pathogenic nonsense mutation associated with MFS [<xref ref-type="bibr" rid="CR36">36</xref>], and deposited in HGMD (accession ID: CM161831). This nonsense substitution truncates the protein at codon 883, which is 1989 amino acids from the end of the protein. According to the ACMG guidelines for classifying pathogenic variants [<xref ref-type="bibr" rid="CR37">37</xref>], this nonsense mutation is a convincing pathogenic LoF allele based on the following evidences: (a) PVS1: this nonsense variant is interpreted at the internal part of <italic>FBN1</italic> gene where LoF is a known mechanism [<xref ref-type="bibr" rid="CR38">38</xref>]; (b) PP1: cosegregation with CS phenotypes in the affected family members; (c)PP3: multiple computational evidence supports highly deleterious properties (Mutation Taster prediction shows deleterious; conservation prediction score by GERP is 4.81; CADD score is 42); (d)PP5: Franken et al. recently reported this variant as a pathogenic LoF allele associated with MFS, but the detailed evaluations for spinal/vertebral phenotypes were unavailable [<xref ref-type="bibr" rid="CR36">36</xref>]. Notably, it has been widely reported that the high degree of clinical variability associated with <italic>FBN1</italic> variants. For instance, distinct genetic mechanisms, encompassing a second deleterious variant in another gene or a polygenic model involving modifier loci, are proposed to account for this clinical variability [<xref ref-type="bibr" rid="CR39">39</xref>]. Thus, the occurrence of a pathogenic variant in <italic>FBN1</italic> is not necessarily associated with or produces MFS. Consistently with our findings, some <italic>FBN1</italic> nonsense mutations (c.284C&gt;A, p.Ser95Ter; c.1347_1348dupTA, p.Thr450IlefsTer130) only caused isolated skeletal features, with no cardiac or ocular findings [<xref ref-type="bibr" rid="CR40">40</xref>]. Pathogenic <italic>FBN1</italic> variants cause MFS but can also be found in patients presenting with apparently isolated features. For instance, the c.1453C&gt;T, p.(Arg485Cys) mutation in <italic>FBN1</italic> has been identified in both autosomal dominant and recessive diseases characterized by a high extent of phenotypic variability [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. Hence, it is reasonable to postulate that the c.2649G&gt;A allele, which has been associated with MFS, could also account for the isolated CS in our study.</p>
<p id="Par24"><italic>FBN1</italic> is implicated in vertebral growth and development [<xref ref-type="bibr" rid="CR43">43</xref>]. Fibrillin microfibrils in the calf are ubiquitously distributed in the vertebral growth plate and involved in growth factor binding, playing a pivotal role in regulating bone growth [<xref ref-type="bibr" rid="CR43">43</xref>]. Moreover, a murine model with an intragenic duplication of <italic>Fbn1</italic> presented markedly enlarged lumbar vertebra and elongated costal cartilages [<xref ref-type="bibr" rid="CR44">44</xref>]. Functional follow-up of <italic>Fbn1</italic><sup>Tsk</sup> mouse unveiled the interactions of <italic>FBN1</italic> with the Wnt signaling pathway [<xref ref-type="bibr" rid="CR45">45</xref>] and its pivotal role for somitegenesis and vertebrate segmentation [<xref ref-type="bibr" rid="CR4">4</xref>]. Since CS is induced by localized changes in vertebral body development [<xref ref-type="bibr" rid="CR46">46</xref>], we proposed that factors distorting the normal localization process of the spine column may contribute to the pathogenesis of CS, such as <italic>FBN1</italic>.</p>
<p id="Par25">TGF-β plays critical roles in development and maintenance of the skeleton [<xref ref-type="bibr" rid="CR47">47</xref>]. The two unrelated patients (XH73 and XH579) sharing the p.Leu871Phe variant presented CS with vertebral segmentation defects, rib anomalies, and diastematomyelia. Our in vitro experimental results showed upregulation of the TGF-β signaling by the p.Leu871Phe variant, supporting the pathogenicity of the mutation. TGF-β signaling plays a critical role in cartilage and spine tissue development, upregulation of the TGF-β signaling pathway within the intervertebral disc could cause the occurrence of vertebral fusions [<xref ref-type="bibr" rid="CR48">48</xref>]. The observations suggest that the upregulation of the TGF-β signaling pathway confer susceptibility to CS. In prior reports, the excess TGF-β activation and signaling have been frequently observed in <italic>FBN1</italic>-deficient humans and mice [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR49">49</xref>].</p>
<p id="Par26">Regarding a mutational burden test for CS with a complex disease trait, the most important thing is not to focus disproportionately on specific variants, but rather to integrate across all types of risk-associated variants. In some individuals, risk may be caused by an unusual combination of common variants and rare variants, like the TACS compound inheritance model [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR8">8</xref>], whereas in others it may be due to an accumulation of rare or ultra-rare variants. In this context, it seemed actionable to stratify the <italic>FBN1</italic> variants by the mutation types and CADD C-score prior to detecting the association by the collapsing method [<xref ref-type="bibr" rid="CR25">25</xref>]. The knowledge about the variants associated with CS and the variable genetic penetrance will blaze the trail for genetic counseling and evaluating of the relatives of the variant carriers.</p>
<p id="Par27">In conclusion, our observations indicated that <italic>FBN1</italic> may be a susceptibility gene for CS, expanding our knowledge to the existing list of predisposition and candidate genes in CS phenotypes. It remains unknown why distinct mutations in the <italic>FBN1</italic> gene can convey a variable continuum of skeletal disorders, ranging from the overlapping features to discordant phenotypes. Future studies focusing on exploring the underlying mechanisms of pleiotropic effects of <italic>FBN1</italic> may be warranted.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec17">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="10038_2019_698_MOESM1_ESM.docx"><caption><p>Table S1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="10038_2019_698_MOESM2_ESM.docx"><caption><p>Table S2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="10038_2019_698_MOESM3_ESM.pptx"><caption><p>Figure S1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="10038_2019_698_MOESM4_ESM.pptx"><caption><p>Figure S2</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>Members of the Deciphering Disorders Involving Scoliosis and COmorbidities (DISCO) study are listed below Acknowledgements.</p>
</fn>
<fn>
<p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p>The online version of this article (10.1038/s10038-019-0698-x) contains supplementary material, which is available to authorized users.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We are grateful to the patients, their families, clinical surgeons, and genetic counselors for providing samples and clinical histories. This research was supported in part by the National Natural Science Foundation of China (81822030 to NW, 81772299 and 81930068 to ZHW, 81672123 and 81972037 to JGZ, 81772301 and 81972132 to GXQ, 81572097 and 81871746 to YPW, 81902271 to GL, 81902178 to SRW), Beijing Natural Science Foundation (7191007 to ZHW, 7172175 to NW, 7184232 to SL,), CAMS Initiative Fund for Medical Sciences (2016-I2M-3-003 to GXQ, NW and ZW, 2016-I2M-2-006 and 2017-I2M-2-001 to ZHW), the Central Level Public Interest Program for Scientific Research Institute (2018RC31003 to NW and Mao Lin), the International Program Associate grant from RIKEN of Japan (190038 to ML), grants from Japan Agency For Medical Research and Development (AMED) (18ek0109280, 18ek0109212 to SI), the National Key Research and Development Program of RIKEN &amp; Ministry of Science and Technology of China (RIKEN-MOST) (2016YFE0128400, to SI and ZW), RIKEN Incentive Research Projects (201801062228 to ZW), and the National Key Research and Development Program of China (No. 2018YFC0910506 to NW and ZHW, 2016YFC0901501 to SYZ).</p>
<sec id="FPar1">
<title>Deciphering Disorders Involving Scoliosis and COmorbidities (DISCO) study</title>
<p id="Par28">Guixing Qiu<sup>1,4,9</sup>, Zhihong Wu<sup>4,8,9</sup>, Jianguo Zhang<sup>1,4,9</sup>, Nan Wu<sup>1,4,9</sup>, Shengru Wang<sup>1</sup>, Jiaqi Liu<sup>4,5</sup>, Sen Liu<sup>1,4</sup>, Yuzhi Zuo<sup>1</sup>, Gang Liu<sup>1,4</sup>, Yuanqiang Zhang<sup>1,2</sup>, Chenxi Yu<sup>1,2</sup>, Sen Zhao<sup>1,4</sup>, Lianlei Wang<sup>1,2</sup>, Yanxue Zhao<sup>1</sup>, Zihui Yan<sup>1,2</sup>, Xinzhuang Yang<sup>8</sup>, Hengqiang Zhao<sup>10</sup>, Yuchen Niu<sup>8</sup>, Mao Lin<sup>1,2,3</sup>, Jiachen Lin<sup>1</sup>.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Author contributions</title>
<p>ML and NW performed the research, analyzed and interpreted the data. ML and NW drafted the manuscript. SZ, GL, YZH, CXY, YXZ, SL, JQL, YYY, YPC, XY, and BDT helped sample collection. LLW, YQZ, and SRW performed phenotyping of patients. ZHY and XZY helped analysis and interpretation of ES data. YCN and XXL provided technique support. YPW, SYZ, ZW, SI, GXQ, and JGZ offered professional discussions and instructions. JZS, JY, and HQZ helped bioinformatic analyses. ZHW and NW conceived and designed the study, revised the manuscript, and provided final approval of the manuscript.</p>
</notes>
<notes notes-type="ethics">
<title>Compliance with ethical standards</title>
<notes notes-type="COI-statement">
<title>Conflict of interest</title>
<p id="Par29">The authors declare that they have no conflict of interest.</p>
</notes>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hedequist</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Emans</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Congenital scoliosis: a review and update</article-title>
<source/>J Pediatr Orthop
          <year>2007</year>
<volume>27</volume>
<fpage>106</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="pmid">17195809</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wynne-Davies</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Congenital vertebral anomalies: aetiology and relationship to. spina bifida cystica</article-title>
<source/>J Med Genet
          <year>1975</year>
<volume>12</volume>
<fpage>280</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">1100836</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Abnormalities associated with congenital. scoliosis: a retrospective study of 226 Chinese surgical cases</article-title>
<source/>Spine.
          <year>2013</year>
<volume>38</volume>
<fpage>814</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">23197014</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pourquie</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Vertebrate segmentation: from cyclic gene networks to scoliosis</article-title>
<source/>Cell.
          <year>2011</year>
<volume>145</volume>
<fpage>650</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">21620133</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sparrow</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Mattar</surname>
<given-names>MZ</given-names>
</name>
<name>
<surname>Major</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>O'Reilly</surname>
<given-names>VC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A mechanism for gene-environment interaction in the etiology of congenital scoliosis</article-title>
<source/>Cell.
          <year>2012</year>
<volume>149</volume>
<fpage>295</fpage>
<lpage>306</lpage>
<pub-id pub-id-type="pmid">22484060</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<mixed-citation publication-type="other">Wu N, Ming X, Xiao J, Wu Z, Chen X, Shinawi M, et al. TBX6 null variants and a common hypomorphic allele in congenital scoliosis. N Engl J Med. 2015;372:341–50.</mixed-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Nan</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Nan</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Ling</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Yanxue</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Jiaqi</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Xiangyu</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>Xiaojun</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Weiyu</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Weisheng</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Shuangshuang</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Sen</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Jiachen</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>Hang</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>Huadan</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Lu</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Hao</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Jianguo</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Jiangang</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Shuyang</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Daru</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Xiaohui</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Li</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>Jiandong</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Guixing</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Zhihong</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>James R</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Feng</given-names>
</name>
</person-group>
<article-title>TBX6 compound inheritance leads to congenital vertebral malformations in humans and mice</article-title>
<source/>Human Molecular Genetics
          <year>2018</year>
<volume>28</volume>
<issue>4</issue>
<fpage>539</fpage>
<lpage>547</lpage>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Jiaqi</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Nan</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Nan</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>Kazuki</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Weisheng</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Weiyu</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Renqian</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Sen</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Yangzhong</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Ling</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Zhenlei</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>Yuzhi</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Sen</given-names>
</name>
<name>
<surname>Blank</surname>
<given-names>Robert</given-names>
</name>
<name>
<surname>Pehlivan</surname>
<given-names>Davut</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Shuangshuang</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Jianguo</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Jianxiong</given-names>
</name>
<name>
<surname>Si</surname>
<given-names>Nuo</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Yipeng</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Gang</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Shugang</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Yanxue</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Hong</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Yixin</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Yu</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Xiaofei</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Jianhua</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Mao</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Ye</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Bo</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Keyi</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>Yuchen</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Bin</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Xiaoxin</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Jia</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Zihui</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Qiankun</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>Xiaolu</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Xiaoli</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Jianzhong</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Xiuli</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Xiaoyue</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>Yue</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Xiao</given-names>
</name>
<name>
<surname>Raggio</surname>
<given-names>Cathleen L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Baozhong</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>Xisheng</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Shuyang</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Xue</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>Kota</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>Morio</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Li</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Yiping</given-names>
</name>
<name>
<surname>Sobreira</surname>
<given-names>Nara L.</given-names>
</name>
<name>
<surname>Posey</surname>
<given-names>Jennifer E.</given-names>
</name>
<name>
<surname>Giampietro</surname>
<given-names>Philip F.</given-names>
</name>
<name>
<surname>Valle</surname>
<given-names>David</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Pengfei</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Zhihong</given-names>
</name>
<name>
<surname>Ikegawa</surname>
<given-names>Shiro</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>James R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Feng</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Guixing</given-names>
</name>
</person-group>
<article-title>TBX6-associated congenital scoliosis (TACS) as a clinically distinguishable subtype of congenital scoliosis: further evidence supporting the compound inheritance and TBX6 gene dosage model</article-title>
<source/>Genetics in Medicine
          <year>2019</year>
<volume>21</volume>
<issue>7</issue>
<fpage>1548</fpage>
<lpage>1558</lpage>
<pub-id pub-id-type="pmid">30636772</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Otomo</surname>
<given-names>Nao</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>Kazuki</given-names>
</name>
<name>
<surname>Kawai</surname>
<given-names>Shunsuke</given-names>
</name>
<name>
<surname>Kou</surname>
<given-names>Ikuyo</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Long</given-names>
</name>
<name>
<surname>Osawa</surname>
<given-names>Mitsujiro</given-names>
</name>
<name>
<surname>Alev</surname>
<given-names>Cantas</given-names>
</name>
<name>
<surname>Kawakami</surname>
<given-names>Noriaki</given-names>
</name>
<name>
<surname>Miyake</surname>
<given-names>Noriko</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>Naomichi</given-names>
</name>
<name>
<surname>Yasuhiko</surname>
<given-names>Yukuto</given-names>
</name>
<name>
<surname>Kotani</surname>
<given-names>Toshiaki</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>Teppei</given-names>
</name>
<name>
<surname>Uno</surname>
<given-names>Koki</given-names>
</name>
<name>
<surname>Sudo</surname>
<given-names>Hideki</given-names>
</name>
<name>
<surname>Inami</surname>
<given-names>Satoshi</given-names>
</name>
<name>
<surname>Taneichi</surname>
<given-names>Hiroshi</given-names>
</name>
<name>
<surname>Shigematsu</surname>
<given-names>Hideki</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>Kei</given-names>
</name>
<name>
<surname>Yonezawa</surname>
<given-names>Ikuho</given-names>
</name>
<name>
<surname>Sugawara</surname>
<given-names>Ryo</given-names>
</name>
<name>
<surname>Taniguchi</surname>
<given-names>Yuki</given-names>
</name>
<name>
<surname>Minami</surname>
<given-names>Shohei</given-names>
</name>
<name>
<surname>Kaneko</surname>
<given-names>Kazuo</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>Masaya</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>Morio</given-names>
</name>
<name>
<surname>Toguchida</surname>
<given-names>Junya</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>Kota</given-names>
</name>
<name>
<surname>Ikegawa</surname>
<given-names>Shiro</given-names>
</name>
</person-group>
<article-title>Bi-allelic loss of function variants of TBX6 causes a spectrum of malformation of spine and rib including congenital scoliosis and spondylocostal dysostosis</article-title>
<source/>Journal of Medical Genetics
          <year>2019</year>
<volume>56</volume>
<issue>9</issue>
<fpage>622</fpage>
<lpage>628</lpage>
<pub-id pub-id-type="pmid">31015262</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giampietro</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Pourquie</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Raggio</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ikegawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Turnpenny</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Summary of the first inaugural joint meeting of the International Consortium for scoliosis genetics and the International Consortium for vertebral anomalies and scoliosis, March 16-18, 2017, Dallas</article-title>
<source/>Tex Am J Med Genet A
          <year>2018</year>
<volume>176</volume>
<fpage>253</fpage>
<lpage>6</lpage>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burnei</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gavriliu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vlad</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Georgescu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ghita</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Dughila</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Congenital scoliosis: an up-to-date</article-title>
<source/>J Med Life
          <year>2015</year>
<volume>8</volume>
<fpage>388</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="pmid">26351546</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giampietro</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Raggio</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Shukla</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>McPherson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ghebranious</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An analysis of <italic>PAX1</italic> in the development of vertebral malformations</article-title>
<source/>Clin Genet
          <year>2005</year>
<volume>68</volume>
<fpage>448</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="pmid">16207213</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>LX</given-names>
</name>
<name>
<surname>Paria</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Henkelman</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Wise</surname>
<given-names>CA</given-names>
</name>
<etal></etal>
</person-group>
<article-title><italic>ptk7</italic> mutant zebrafish models of congenital and idiopathic scoliosis implicate dysregulated Wnt signalling in disease</article-title>
<source/>Nat Commun.
          <year>2014</year>
<volume>5</volume>
<fpage>4777</fpage>
<pub-id pub-id-type="pmid">25182715</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barhoumi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nashabat</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Alghanem</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Alhallaj</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Boudjelal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Umair</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Delta like-1 gene mutation: a novel cause of congenital vertebral malformation</article-title>
<source/>Front Genet.
          <year>2019</year>
<volume>10</volume>
<fpage>534</fpage>
<pub-id pub-id-type="pmid">31275352</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bargal</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cormier-Daire</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ben-Neriah</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Le Merrer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sosna</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Melki</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in <italic>DDR2</italic> gene cause SMED with short limbs and abnormal calcifications</article-title>
<source/>Am J Hum Genet
          <year>2009</year>
<volume>84</volume>
<fpage>80</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="pmid">19110212</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Progress and perspective of <italic>TBX6</italic> gene in congenital vertebral malformations</article-title>
<source/>Oncotarget.
          <year>2016</year>
<volume>7</volume>
<fpage>57430</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="pmid">27437870</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Perturbations of BMP/TGF-beta and VEGF/VEGFR signalling pathways in non-syndromic sporadic brain arteriovenous malformations (BAVM)</article-title>
<source/>J Med Genet
          <year>2018</year>
<volume>55</volume>
<fpage>675</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="pmid">30120215</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaser</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Adusumalli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Leng</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Sikic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>SIFT missense predictions for genomes</article-title>
<source/>Nat Protoc.
          <year>2016</year>
<volume>11</volume>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">26633127</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adzhubei</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Peshkin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ramensky</surname>
<given-names>VE</given-names>
</name>
<name>
<surname>Gerasimova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bork</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A method and server for predicting damaging missense mutations</article-title>
<source/>Nat Methods.
          <year>2010</year>
<volume>7</volume>
<fpage>248</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">20354512</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Rodelsperger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schuelke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Seelow</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>MutationTaster evaluates disease-causing potential of sequence alterations</article-title>
<source/>Nat methods.
          <year>2010</year>
<volume>7</volume>
<fpage>575</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">20676075</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kircher</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Witten</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>P</given-names>
</name>
<name>
<surname>O'Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Shendure</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A general framework for estimating the relative pathogenicity of human genetic variants</article-title>
<source/>Nat Genet.
          <year>2014</year>
<volume>46</volume>
<fpage>310</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">24487276</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carson</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Matsui</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Braekkan</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Jepsen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>JB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effective filtering strategies to improve data quality from population-based whole exome sequencing studies</article-title>
<source/>BMC Bioinformatics
          <year>2014</year>
<volume>15</volume>
<fpage>125</fpage>
<pub-id pub-id-type="pmid">24884706</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dharmadhikari</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Varland</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Domingo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kleyner</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Truncating variants in <italic>NAA15</italic> are associated with variable levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies</article-title>
<source/>Am J Hum Genet
          <year>2018</year>
<volume>102</volume>
<fpage>985</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="pmid">29656860</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collod-Beroud</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Le Bourdelles</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ades</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ala-Kokko</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Booms</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Boxer</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Update of the UMD-<italic>FBN1</italic> mutation database and creation of an <italic>FBN1</italic> polymorphism database</article-title>
<source/>Hum Mutat.
          <year>2003</year>
<volume>22</volume>
<fpage>199</fpage>
<lpage>208</lpage>
<pub-id pub-id-type="pmid">12938084</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Leal</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data</article-title>
<source/>Am J Hum Genet
          <year>2008</year>
<volume>83</volume>
<fpage>311</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="pmid">18691683</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersen</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Terczynska-Dyla</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mork</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Scavenius</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Enghild</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Honing</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Frequently used bioinformatics tools overestimate the damaging effect of allelic variants</article-title>
<source/>Genes Immun
          <year>2019</year>
<volume>20</volume>
<fpage>10</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="pmid">29217828</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Rasband</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Eliceiri</surname>
<given-names>KW</given-names>
</name>
</person-group>
<article-title>NIH Image to ImageJ: 25 years of image analysis</article-title>
<source/>Nat methods.
          <year>2012</year>
<volume>9</volume>
<fpage>671</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">22930834</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loeys</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Dietz</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Braverman</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Callewaert</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>De Backer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Devereux</surname>
<given-names>RB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The revised Ghent nosology for the Marfan syndrome</article-title>
<source/>J Med Genet
          <year>2010</year>
<volume>47</volume>
<fpage>476</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="pmid">20591885</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buchan</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Alvarado</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Haller</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Cruchaga</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Harms</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rare variants in <italic>FBN1</italic> and <italic>FBN2</italic> are associated with severe adolescent idiopathic scoliosis</article-title>
<source/>Hum Mol Genet
          <year>2014</year>
<volume>23</volume>
<fpage>5271</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="pmid">24833718</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Redfield</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Handford</surname>
<given-names>PA</given-names>
</name>
</person-group>
<article-title>Structure and interdomain interactions of a hybrid domain: a disulphide-rich module of the fibrillin/LTBP superfamily of matrix proteins</article-title>
<source/>Structure.
          <year>2009</year>
<volume>17</volume>
<fpage>759</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="pmid">19446531</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mellody</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Baldock</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jowitt</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Siegler</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Raynal</surname>
<given-names>BD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Marfan syndrome-causing mutations in <italic>fibrillin-1</italic> result in gross morphological alterations and highlight the structural importance of the second hybrid domain</article-title>
<source/>J Biol Chem
          <year>2006</year>
<volume>281</volume>
<fpage>31854</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="pmid">16905551</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Handford</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Downing</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hewett</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Sykes</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Kielty</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>The calcium binding properties and molecular organization of epidermal growth factor-like domains in human fibrillin-1</article-title>
<source/>J Biol Chem
          <year>1995</year>
<volume>270</volume>
<fpage>6751</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">7896820</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andelfinger</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Loeys</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dietz</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>A decade of discovery in the genetic understanding of thoracic aortic disease</article-title>
<source/>Can J Cardiol
          <year>2016</year>
<volume>32</volume>
<fpage>13</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="pmid">26724507</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Stoddard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Crandall</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Recapitulating and correcting Marfan Syndrome in a cellular model</article-title>
<source/>Int J Biol Sci
          <year>2017</year>
<volume>13</volume>
<fpage>588</fpage>
<lpage>603</lpage>
<pub-id pub-id-type="pmid">28539832</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ades</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Sreetharan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Onikul</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Stockton</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Holman</surname>
<given-names>KJ</given-names>
</name>
</person-group>
<article-title>Segregation of a novel <italic>FBN1</italic> gene mutation, G1796E, with kyphoscoliosis and radiographic evidence of vertebral dysplasia in three generations</article-title>
<source/>Am J Med Genet
          <year>2002</year>
<volume>109</volume>
<fpage>261</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="pmid">11992479</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franken</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Groenink</surname>
<given-names>M</given-names>
</name>
<name>
<surname>de Waard</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Feenstra</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Scholte</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>van den Berg</surname>
<given-names>MP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genotype impacts survival in Marfan syndrome</article-title>
<source/>Eur Heart J
          <year>2016</year>
<volume>37</volume>
<fpage>3285</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="pmid">26787436</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richards</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aziz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bale</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bick</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gastier-Foster</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>
<source/>Genet Med.
          <year>2015</year>
<volume>17</volume>
<fpage>405</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">25741868</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizuguchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Recent progress in genetics of Marfan syndrome and Marfan-associated disorders</article-title>
<source/>J Hum Genet
          <year>2007</year>
<volume>52</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">17061023</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aubart</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gazal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arnaud</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Benarroch</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Buratti</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of modifiers and other genetic factors explain Marfan syndrome clinical variability</article-title>
<source/>Eur J Hum Genet
          <year>2018</year>
<volume>26</volume>
<fpage>1759</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="pmid">30087447</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Groth</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Von Kodolitsch</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kutsche</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gaustadnes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thorsen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>NH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evaluating the quality of Marfan genotype-phenotype correlations in existing <italic>FBN1</italic> databases</article-title>
<source/>Genet Med.
          <year>2017</year>
<volume>19</volume>
<fpage>772</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">27906200</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Overwater</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Efrat</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Barge-Schaapveld</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lakeman</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Maugeri</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Autosomal dominant Marfan syndrome caused by a previously reported recessive <italic>FBN1</italic> variant</article-title>
<source/>Mol Genet Genom Med
          <year>2019</year>
<volume>7</volume>
<fpage>e00518</fpage>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Vries</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Pals</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Odink</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hamel</surname>
<given-names>BC</given-names>
</name>
</person-group>
<article-title>Homozygosity for a <italic>FBN1</italic> missense mutation: clinical and molecular evidence for recessive Marfan syndrome</article-title>
<source/>Eur J Hum Genet
          <year>2007</year>
<volume>15</volume>
<fpage>930</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">17568394</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Urban</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Immunolocalisation of fibrillin microfibrils in the calf metacarpal and vertebral growth plate</article-title>
<source/>J Anat.
          <year>2013</year>
<volume>223</volume>
<fpage>641</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="pmid">24117386</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barisic-Dujmovic</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Boban</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Marfan-like skeletal phenotype in the tight skin (Tsk) mouse</article-title>
<source/>Calcif Tissue Int
          <year>2007</year>
<volume>81</volume>
<fpage>305</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="pmid">17705049</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayle</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fitch</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lafyatis</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lemaire</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Increased expression of <italic>Wnt2</italic> and <italic>SFRP4</italic> in Tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis</article-title>
<source/>J Investig Dermatol
          <year>2008</year>
<volume>128</volume>
<fpage>871</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="pmid">17943183</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giampietro</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Blank</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Raggio</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Merchant</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>FS</given-names>
</name>
<name>
<surname>Faciszewski</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Congenital and idiopathic scoliosis: clinical and genetic aspects</article-title>
<source/>Clin Med Res
          <year>2003</year>
<volume>1</volume>
<fpage>125</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="pmid">15931299</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacFarlane</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Haupt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dietz</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Shore</surname>
<given-names>EM</given-names>
</name>
</person-group>
<article-title>TGF-beta family signaling in connective tissue and skeletal diseases</article-title>
<source/>Cold Spring Harb Perspect Biol
          <year>2017</year>
<volume>9</volume>
<fpage>a022269</fpage>
<pub-id pub-id-type="pmid">28246187</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zieba</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Forlenza</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Khatra</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Sarukhanov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Duran</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Rigueur</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TGFbeta and BMP dependent cell fate changes due to loss of filamin B produces disc degeneration and progressive vertebral fusions</article-title>
<source/>PLoS Genet
          <year>2016</year>
<volume>12</volume>
<fpage>e1005936</fpage>
<pub-id pub-id-type="pmid">27019229</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Martinez-Murillo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Jie</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bedja</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome</article-title>
<source/>J Clin Investig
          <year>2004</year>
<volume>114</volume>
<fpage>1586</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="pmid">15546004</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>